Olaparib (trade name Lynparza) is an oral chemotherapy drug used to treat advanced ovarian cancer and some other types of cancer. It is a molecularly targeted drug, meaning it is designed to work specifically on certain types of cancer cells. It works by blocking enzymes known as PARP enzymes, which cancer cells use to repair their DNA. By blocking these enzymes, Olaparib prevents cancer cells from repairing themselves and makes them more susceptible to the effects of chemotherapy. Olaparib is usually taken in combination with other chemotherapy drugs to increase its effectiveness.
Olaparib is a prescription medication used to treat specific types of cancer in individuals with genetic mutations that make them more susceptible to the effects of the drug. Here's a detailed breakdown of its key characteristics:
Function:
- PARP inhibitor: Olaparib belongs to a class of drugs called poly (ADP-ribose) polymerase (PARP) inhibitors. PARP is an enzyme involved in DNA repair mechanisms within cells.
- Targets cancers with BRCA mutations: Olaparib works by selectively targeting and inhibiting PARP in cancer cells with mutations in specific genes, particularly BRCA1 and BRCA2. These genes play a vital role in DNA repair, and their mutations can lead to uncontrolled cell growth and tumor formation.
Applications:
- Ovarian cancer: Olaparib is approved for treating:
- Advanced ovarian cancer: In women with BRCA mutations, who have either not responded adequately to initial treatment (first-line therapy) or whose cancer has recurred (relapsed) after responding to previous treatment.
- Maintenance therapy: To help maintain disease-free status following successful first-line treatment for BRCA-mutated ovarian cancer.
- Breast cancer: It's also indicated for:
- Metastatic breast cancer: In individuals with BRCA mutations, where the cancer has spread to other parts of the body.
- HER2-negative breast cancer: For patients with BRCA mutations and a specific subtype of breast cancer that is negative for the HER2 receptor.
Important Considerations:
- Genetic testing required: Olaparib treatment is only recommended for individuals who have undergone genetic testing and confirmed mutations in the BRCA1 or BRCA2 genes.
- Prescription medication: It's a powerful drug and should only be administered under the strict supervision of a qualified oncologist specializing in cancer treatment.
- Potential side effects: Like any medication, Olaparib can cause various side effects, including:
- Fatigue
- Nausea
- Vomiting
- Diarrhea
- Loss of appetite
- Anemia (low red blood cell count)
- Increased risk of infections